Status:
TERMINATED
Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Vitreoretinal Traction Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Plasmin is expected to create a posterior vitreous detachment. The pharmacological creation of a posterior vitreous detachment may be beneficial in a variety of conditions.
Eligibility Criteria
Inclusion
- Patients who would benefit from a posterior vitreous detachment, as determined by the evaluating ophthalmologist.
Exclusion
- Presence of a posterior vitreous detachment in the study eye
- History of vitrectomy in the study eye
- Proliferative diabetic retinopathy in the study eye
- Presence of media opacity that precludes quality examination of the vitreous and fundus.
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT00348439
Start Date
April 1 2006
End Date
August 1 2007
Last Update
June 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30322